Skip to content

Author

Amrita Singh

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

The 1,3,4-Thiadiazole Scaffold in Medicinal Chemistry: Structural Insights, Mechanistic Pathways, and Therapeutic Outlook.

Heteroatoms are common structural fragments in many APIs and excipients. Several heterocyclic scaffolds are considered privileged structures. The term Thiadiazole comes from the "Hantzsch-Widman" nomenclature and falls within the category of azole chemicals. These are heterocyclic compounds with 5-membered rings that c...

Ayushi Katiyar, Ajay Kumar, S. Misra et al. · 0 citations
Review Open access 2026

Histone Deacetylases and Their Inhibitors: Classification, Clinical Development, and FDA-Approved Therapeutic Indications

Histone deacetylases (HDACs) are vital regulators of gene expression and chromatin structure. Their abnormal overactivity has been closely linked to the progression of various solid tumors, making them a significant focus of cancer research. HDAC inhibitors (HDACis) have shown clinical promise, particularly in the trea...

Amrita Singh, Deepak Singh · 0 citations
Sep 2026

Structure-based discovery of coumarin-derived HDAC2 inhibitor through integrated computational bioassays, steered molecular dynamics, network analysis and SAR

A structure–activity relationship (SAR)-guided strategy was employed to identify novel coumarin-based HDAC2 inhibitors, highlighting the coumarin scaffold, an additional aromatic ring, a 3–6 atom linker, a furan bridge, and terminal hydroxyl or methoxy groups as key structural features.

Amrita Singh, Deepak Singh · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.